Works matching IS 02694727 AND DT 2022 AND VI 47 AND IP 5
Results: 22
Challenges for expansion of thoracic transplant clinical pharmacy in a developing country: comparison with U.S. accredited centres and call for action.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 588, doi. 10.1111/jcpt.13577
- By:
- Publication type:
- Article
The epidemiology of apnoea of prematurity.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 685, doi. 10.1111/jcpt.13587
- By:
- Publication type:
- Article
Risk of cardiovascular disease in breast cancer patients receiving aromatase inhibitors vs. tamoxifen: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 575, doi. 10.1111/jcpt.13598
- By:
- Publication type:
- Article
Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 676, doi. 10.1111/jcpt.13597
- By:
- Publication type:
- Article
Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 668, doi. 10.1111/jcpt.13596
- By:
- Publication type:
- Article
Body mass index and pharmacodynamics of target‐controlled infusion of propofol: A prospective non‐randomized controlled study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 662, doi. 10.1111/jcpt.13594
- By:
- Publication type:
- Article
Clinical practice guidelines for management of dual antiplatelet therapy in patients with noncardiac surgery: A critical appraisal using the AGREE II instrument.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 652, doi. 10.1111/jcpt.13593
- By:
- Publication type:
- Article
Comment on: 'Detecting drug‐drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system' by Matsuo et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Clinical outcomes and safety of osimertinib plus anlotinib for patients with previously treated EGFR T790M‐positive NSCLC: A retrospective study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 643, doi. 10.1111/jcpt.13591
- By:
- Publication type:
- Article
Pravastatin concentrations in maternal serum, umbilical cord serum, breast milk and neonatal serum during pregnancy and lactation: A case study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 703, doi. 10.1111/jcpt.13590
- By:
- Publication type:
- Article
Comparing safety of proton‐pump inhibitors versus H2‐receptor antagonists in kidney transplant recipients: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 567, doi. 10.1111/jcpt.13589
- By:
- Publication type:
- Article
Three new categories of hypoglycaemic agents and various cardiovascular diseases: A meta‐analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 636, doi. 10.1111/jcpt.13588
- By:
- Publication type:
- Article
Does COVID‐19 increase tacrolimus levels in kidney transplant recipients?
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 707, doi. 10.1111/jcpt.13586
- By:
- Publication type:
- Article
Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 699, doi. 10.1111/jcpt.13585
- By:
- Publication type:
- Article
Retraction: Calcitonin Gene‐Related Peptide (CGRP) Antagonists: A comprehensive review of safety, efficacy and prescribing information.
- Published in:
- 2022
- Publication type:
- Correction Notice
Comparison of antimicrobial dosing recommendations in patients receiving intermittent hemodialysis among drug information resources.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 628, doi. 10.1111/jcpt.13583
- By:
- Publication type:
- Article
Administering esomeprazole subcutaneously via a syringe driver in the palliative demographic: A case series.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 694, doi. 10.1111/jcpt.13582
- By:
- Publication type:
- Article
Intervention fidelity and process outcomes of the IMMENSE study, a pharmacist‐led interdisciplinary intervention to improve medication safety in older hospitalized patients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 619, doi. 10.1111/jcpt.13581
- By:
- Publication type:
- Article
Correlation between CA12 and TFF3 and their prediction value of neoadjuvant chemotherapy response in breast cancer.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 609, doi. 10.1111/jcpt.13580
- By:
- Publication type:
- Article
Machine learning‐based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 600, doi. 10.1111/jcpt.13579
- By:
- Publication type:
- Article
Evaluation of desensitization protocols to betalactam antibiotics.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. 592, doi. 10.1111/jcpt.13578
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 5, p. i, doi. 10.1111/jcpt.13440
- Publication type:
- Article